Shares of Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as C$0.27 and last traded at C$0.27, with a volume of 118690 shares. The stock had previously closed at C$0.28.
Nanalysis Scientific Stock Performance
The company has a market capitalization of C$31.09 million, a price-to-earnings ratio of -2.33 and a beta of 0.72. The stock’s 50 day moving average price is C$0.36 and its 200 day moving average price is C$0.39. The company has a current ratio of 1.42, a quick ratio of 1.11 and a debt-to-equity ratio of 71.72.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Further Reading
- Five stocks we like better than Nanalysis Scientific
- Stock Analyst Ratings and Canadian Analyst Ratings
- The Great CPU Race: AMD and Intel Battle for Dominance
- What does consumer price index measure?
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- What is a Stock Market Index and How Do You Use Them?
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
